A Study of a Personalized Neoantigen Cancer Vaccine
Condition: Solid Tumor Interventions: Biological: GRT-C901; Biological: GRT-R902; Biological: nivolumab; Biological: ipilimumab Sponsors: Gritstone Oncology, Inc.; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials